Genome-wide association study identifies SESTD1 as a novel risk gene for lithium-responsive bipolar disorder

Lithium is the mainstay prophylactic treatment for bipolar disorder (BD), but treatment response varies considerably across individuals. Patients who respond well to lithium treatment might represent a relatively homogeneous subtype of this genetically and phenotypically diverse disorder. Here, we p...

Full description

Saved in:
Bibliographic Details
Published in:Mol Psychiatry
Main Authors: Song, J, Bergen, S E, Di Florio, A, Karlsson, R, Charney, A, Ruderfer, D M, Stahl, E A, Chambert, K D, Moran, J L, Gordon-Smith, K, Forty, L, Green, E K, Jones, I, Jones, L, Scolnick, E M, Sklar, P, Smoller, J W, Lichtenstein, P, Hultman, C, Craddock, N, Landén, M, Smoller, Jordan W, Perlis, Roy H, Lee, Phil Hyoun, Castro, Victor M, Hoffnagle, Alison G, Sklar, Pamela, Stahl, Eli A, Purcell, Shaun M, Ruderfer, Douglas M, Charney, Alexander W, Roussos, Panos, Michele Pato, Carlos Pato, Medeiros, Helen, Sobel, Janet, Craddock, Nick, Jones, Ian, Forty, Liz, Florio, Arianna Di, Green, Elaine, Jones, Lisa, Gordon-Smith, Katherine, Landen, Mikael, Hultman, Christina, Jureus, Anders, Bergen, Sarah, McCarroll, Steven, Moran, Jennifer, Chambert, Kimberly, Belliveau, Richard A
Format: Artigo
Language:Inglês
Published: Nature Publishing Group 2016
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4995544/
https://ncbi.nlm.nih.gov/pubmed/26503763
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mp.2015.165
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items